Documenting Telemedicine Visits

1. What is the telehealth modality (synchronous video, audio-only, store-and-forward, remote patient monitoring)? Default: synchronous video
2. What is the patient's physical location during the visit (home, workplace, state)? Default: [REQUIRED]
3. What is the provider's location and state of licensure? Default: per credentialing
4. Has the patient provided informed consent for telehealth (documented or on file)? Default: verify
5. What is the reason for the visit (follow-up, acute complaint, chronic disease management, medication refill)? Default: [REQUIRED]
6. Is this visit appropriate for telehealth, or does it require in-person evaluation? Default: assess
7. What E/M code level is anticipated (99211-99215, or telehealth-specific codes)? Default: based on MDM
8. Does the patient have any technology issues affecting the visit (poor video quality, connectivity)? Default: assess during visit

Documents to Request

• Telehealth consent form (signed or verbal consent documentation)
• Patient's stated physical location (address and state)
• Technology platform used (HIPAA-compliant platform name)
• Patient-provided vital signs if available (home BP monitor, glucometer, pulse oximeter, thermometer, weight)
• Current medication list
• Recent labs or imaging results relevant to visit
• Prior visit notes for continuity of care
• Remote patient monitoring (RPM) data if enrolled (BP trends, glucose logs, weight trends)

Step 1: Telehealth Visit Header Documentation

Every telemedicine encounter note MUST contain these elements in the header or visit metadata:

Step 2: Clinical Assessment with Telehealth-Specific Documentation

History of Present Illness (HPI): Standard documentation applies; telehealth does not reduce HPI requirements.

Physical Exam — Telehealth Adaptations:

Critical documentation principle: Explicitly state what CANNOT be assessed and how limitations were mitigated.

Step 3: Patient-Reported Vitals and Remote Monitoring Data

Documentation requirement: Always note the source as "patient-reported" to distinguish from clinician-measured values. If patient does not have monitoring equipment, document: "Home vitals not available; [recommendation for in-person vitals or device provision]."

RPM integration: If enrolled in Remote Patient Monitoring (CPT 99453-99458), reference RPM data trends: "RPM data reviewed: [X]-day average BP [value], [trend description]."

Step 4: Medical Decision-Making and Plan

MDM documentation for telehealth follows standard E/M guidelines (2021 AMA E/M framework):

MDM elements are identical to in-person visits:

• Number and complexity of problems addressed
• Amount and complexity of data reviewed (labs, imaging, external records, RPM data)
• Risk of complications, morbidity, or mortality of management decisions

Telehealth-specific plan elements to document:

1. In-person follow-up need: "Patient should be seen in-person if [symptoms worsen / specific trigger] or at [date] for [exam component not possible via telehealth]"
2. Diagnostic limitations: "Assessment limited by inability to perform [specific exam/test]; clinical diagnosis is [presumptive/working]; differential includes [list]"
3. Safety net instructions: "Patient instructed to go to ED / call 911 if [specific red flag symptoms]. Return precautions reviewed."
4. Prescriptions: Document medical necessity for any medications prescribed, especially if controlled substances (note: DEA requires Ryan Haight Act compliance for Schedule II-V via telehealth)
5. Referrals: Note if in-person specialist evaluation is needed vs. telehealth-capable specialist

Step 5: Billing and Compliance Documentation

Telehealth billing codes (CMS):

State-specific requirements to verify:

• Patient must be in a state where the provider holds an active license (or interstate compact applies)
• Controlled substance prescribing via telehealth: initial in-person visit may still be required per Ryan Haight Act (temporary DEA flexibilities may expire)
• Some states require specific telehealth consent language in writing
• Medicaid telehealth coverage varies significantly by state

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Is the telehealth modality, platform, and consent documented in the visit header?
2. Are patient and provider locations (including states) documented?
3. Are telehealth limitations explicitly stated for each physical exam component not assessable?
4. Is the plan documented with clear in-person follow-up triggers and safety net instructions?
5. Is the billing code appropriate for the modality with correct place-of-service and modifiers?

Quality Audit

• Visit type (telehealth) and modality (video, audio-only, asynchronous) documented
• HIPAA-compliant platform identified by name
• Patient location (city and state) documented for licensure and billing compliance
• Provider location documented
• Informed consent for telehealth documented (verbal or written, with date)
• Technology adequacy noted (audio/video quality sufficient or limitations documented)
• HPI documented at same standard as in-person visit
• Physical exam documents what WAS assessed and what COULD NOT be assessed via telehealth
• Patient-reported vitals labeled as patient-reported with source device noted
• MDM documented at standard E/M level (not reduced because of telehealth)
• Safety net instructions provided with specific red flag symptoms for escalation
• In-person follow-up recommendation documented when telehealth assessment is insufficient
• Prescribing compliance documented (especially for controlled substances — Ryan Haight Act)
• Billing code and POS/modifier are correct for the telehealth modality
• Visit duration (start/end time) documented to support time-based coding if applicable

Guidelines

• Never perform a telehealth visit for conditions requiring hands-on examination that cannot be safely deferred (acute abdomen, chest pain requiring auscultation, new neurologic deficits requiring full exam)
• Always explicitly document what physical exam components could NOT be performed remotely and how this limitation was managed
• Patient-reported vitals must always be labeled as such; do not enter patient-reported BP into vital signs as if clinician-measured
• The standard of care for documentation is identical for telehealth and in-person visits; telehealth does NOT lower documentation requirements
• Controlled substance prescribing via telehealth requires Ryan Haight Act compliance; an in-person exam has historically been required for initial Schedule II-V prescriptions (DEA flexibilities may be temporary)
• Cross-state telehealth requires active licensure in the patient's state unless an interstate compact (IMLC) applies; verify before each visit
• Audio-only visits (telephone) are billed differently from audio-video visits; do not use E/M codes 99211-99215 for telephone-only encounters
• HIPAA applies fully to telehealth; never use non-compliant platforms (personal Zoom, FaceTime, SMS) for clinical encounters unless covered under a public health emergency waiver